How much of CHem RX debt was assumed PMC!
Form 8-K for PHARMERICA CORP 10-Nov-2010
Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
Item 2.01. Completion of Acquisition or Disposition of Assets On November 4, 2010, PharMerica Corporation (the "Company"), through one of its wholly-owned subsidiaries, Chem Rx Pharmacy Services, LLC, a Delaware limited liability company, acquired substantially all of the assets of Chem Rx Corporation and certain of its wholly-owned subsidiaries (collectively, the "Seller") for $70,600,000 in cash plus the assumption of specified liabilities related to the assets. The acquisition of the assets was effectuated through the sale, transfer, and assignment of the assets by the Seller to the Company in a sale undertaken pursuant to Section 363 of the United States Bankruptcy Code.
The Company announced the completion of the acquisition in a Press Release of the Company, dated November 4, 2010.
Item 9.01 Financial Statements and Exhibits. (a) Financial statements of businesses acquired.
The financial statements required to be filed by this Item will be filed with the SEC under cover of Form 8-K/A as soon as practicable, but in no event later than seventy-one (71) days after the date on which this initial report is filed.
(b) Pro forma financial information.
The pro forma financial information required to be filed by this Item will be filed with the SEC under cover of Form 8-K/A as soon as practicable, but in no event later than seventy-one (71) days after the date on which this initial report is filed.
(d) Exhibits
Exhibit No. Description
99.1 Press Release of the Company, dated November 4, 2010 (1)
(1) Filed with the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2010, and incorporated herein by reference.
